Oncology Live®

Vol. 25/No. 1
Volume: 25
Issue: 1

Vol. 24/No. 20
Volume: 24
Issue: 20

Vol. 24/No. 18
Volume: 24

Vol. 24/No. 19
Volume: 24
Issue: 19

Vol. 24/No. 17
Volume: 24
Issue: 17

Vol. 24/No. 16
Volume: 24
Issue: 16

Vol. 24/No. 15
Volume: 24
Issue: 15

Vol. 24/No. 14
Volume: 24
Issue: 14

Vol. 24/No. 12
Volume: 24

Vol. 24/No. 13
Volume: 24
Issue: 13

Vol.24/No.11
Volume: 24
Issue: 11

Vol. 24/ No. 10
Volume: 24
Issue: 10

Vol. 24/No. 9
Volume: 24
Issue: 9

Vol. 24/No. 8
Volume: 24

Vol.24/No.7

Vol. 24/No. 5
Volume: 24

Vol. 24/No. 6
Volume: 24
Issue: 6

Vol. 24/No. 4
Volume: 24

Vol. 24/No. 3
Volume: 24

Vol. 24/No. 2
Volume: 24
Issue: 2

Vol. 24/No. 1
Volume: 24
Issue: 1

Vol. 23/No. 23
Volume: 23

Vol. 23/No. 24
Volume: 23
Issue: 24

Vol. 23/No. 21
Volume: 23

Vol. 23/ No. 22
Volume: 23
Issue: 22

Vol. 23/No. 20
Volume: 23
Issue: 20

Vol. 23/No. 18
Volume: 23
Issue: 18

Vol. 23/No. 17
Volume: 23
Issue: 17

Vol. 23/No. 16
Volume: 23
Issue: 16

Vol. 23/No. 14
Volume: 23
Issue: 14
Advertisement
Advertisement
Trending on OncLive
1
FDA Accepts BLA for Ivonescimab Plus Chemotherapy in EGFR-Mutant NSCLC After TKI Progression
2
Ultra-Sensitive ctDNA and CSF Liquid Biopsy May Refine Monitoring and Adaptive Trial Designs in Metastatic Breast Cancer
3
FDA Grants Fast Track Designation to IBI3003 in Relapsed/Refractory Multiple Myeloma
4
Oncology Fellows Presents a New Drug Cheat Sheet for Fellows
5

